Waltham, MA - Digoxin use is linked to mortality in patients with end-stage renal disease (ESRD), according to the results of a retrospective cohort study reported online June 24, 2010 in the Journal ...

Senior researcher Dr Ali Ahmed (University of Alabama, Birmingham) told heartwire that the differing conclusions are the result of two different methodologies used to analyze the data. He said their ...

Patients with atrial fibrillation taking digoxin are reportedly pose an increased risk of death compared with patients not taking the medication, according to research presented at the American ...

Digoxin use among patients who are on hemodialysis (HD) may increase their risk of death, especially if they have low predialysis potassium levels, a study showed. HD patients who used digoxin had a ...

Please provide your email address to receive an email when new articles are posted on . At 6 months, quality of life in patients with permanent atrial fibrillation and symptomatic HF treated with ...

In patients with heart failure with reduced ejection fraction (HFrEF) who have an implantable cardioverter-defibrillator (ICD), the use of digoxin may increase the risk of ventricular tachyarrhythmia ...

Wearable device data could predict New York Heart Association functional class similarly to clinical measures and 6-minute walk test. (HealthDay News) — For patients with atrial fibrillation, digoxin ...

Gemtesa has interactions with certain other medications. Examples include digoxin and oxybutynin. Talk with your doctor or pharmacist to avoid potentially harmful effects from Gemtesa interactions.